Omada Health CFO Steven Cook Sells Shares

On June 15, 2026, Steven Cook, the Chief Financial Officer of Omada Health, Inc. (NasdaqGS: OMDA), sold 6,800 shares of the company. The shares were sold at an average price of $17.23 each, amounting to a total transaction value of $117,164. This sale was part of a pre-planned trading plan.

Insider Buying and Selling at Omada Health, Inc.

Steven Cook wasn't the only executive selling shares recently. On June 12, 2026, Wei-Li Shao, the President, sold 4,589 shares at $17.24 each, and Craig Gracey, the Chief Accounting Officer, sold 6,894 shares at $17.42 each. Earlier, on June 5, 2026, CEO Sean Duffy sold 9,450 shares, though the transaction did not specify a price.

Other Institutional Activity in Omada Health

In recent months, several institutional investors have adjusted their holdings in Omada Health. Divisadero Street Capital Management, LP increased its position significantly by adding 5,418,118 shares, bringing its total to 5,887,715 shares valued at approximately $74.0 million. On the other hand, FMR LLC reduced its stake by 1,890,124 shares, ending with 3,288,380 shares worth about $41.3 million.

Omada Health, Inc. Stock Down 27.8%

Shares of Omada Health (NasdaqGS: OMDA) are currently trading around $17.33. The company has a market capitalization of approximately $1.02 billion and a forward P/E ratio of 35.9. Over the past 52 weeks, the stock has ranged from a low of $10.28 to a high of $26.92. Its 50-day moving average is $15.57, and the 200-day moving average is $17.32. The company maintains a healthy liquidity position with a current ratio of 3.92 and a quick ratio of 3.69.

Recent Earnings

Omada Health reported revenues of $283.3 million, reflecting a growth rate of 42%. The company, however, posted a net margin of -2.22% and a return on equity of -4.30%. The next earnings report is scheduled for August 6, 2026.

Analysts Set New Price Targets

Several analysts have weighed in on Omada Health's stock. On May 8, 2026, Barclays, Citizens, and Evercore ISI Group all maintained their "buy" ratings with price targets of $20 and $21. Wells Fargo maintained a "hold" rating with a target of $18. The consensus among 12 analysts is a "buy" rating, with a mean price target of $22.92.

About Omada Health

Omada Health, Inc., based in South San Francisco, California, offers a variety of virtual care programs across the United States. The company focuses on cardiometabolic conditions like prediabetes and hypertension, as well as musculoskeletal and behavioral health support. It serves employers, health plans, and pharmacy benefits managers through direct sales and channel partners. Led by CEO Sean P. Duffy, Omada Health employs approximately 943 people.

Bottom Line

The recent insider sales at Omada Health, including those by CFO Steven Cook, are part of planned transactions and may not necessarily indicate a negative outlook. With a robust market presence and ongoing analyst support, investors continue to keep a close watch on the company's performance. Remember, Form 4 filings like these are backward-looking and reflect past transactions.